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In developed countries, the high morbidity associated with
respiratory tract infections and the diﬃculty to discrim-
inate viral from bacterial aetiology support the use of
guidelines based on the observation of clinical signs, such
as the World Health Organisation algorithm. Tachypnoea
is the cardinal clinical sign on which early diagnosis of
pneumonia is to be based in order to allow prompt initi-
ation of appropriate antibiotic therapy.
A key issue in managing respiratory tract infections
(RTI) is to detect cases of bacterial community-acquired
pneumonia (CAP) requiring antibiotic treatment [1,2].
The only validated guideline in children is that proposed
by the World Health Organisation (WHO) [6] which is
based on the observation of ﬁve clinical parameters: re-
spiratory rate (the absence of tachypnoea rules out
CAP), chest retraction, cyanosis, feeding diﬃculty and
absence of wheezing. Diverse combinations of these ﬁve
parameters deﬁne three stages of severity, each calling for
a distinct therapeutic regimen. In order to test the rele-
vance of the WHO guidelines for a developed country,
we applied them in our general paediatric emergency
clinic in the light of routine investigations. In children
with suspected CAP, after clearing the nose and when the
child had returned to a quiet state, respiratory rate was
counted for 1 min on two separate occasions. Tachyp-
noea was deﬁned as any respiratory rate >50/min in
children younger than 1 year or >40/min in children
aged 1–5 years. All children aged 2 months to 5 years
with WHO criteria for CAP were prospectively enrolled.
Children on antibiotics or having received antibiotics
within the previous 2 weeks, those with an underlying
chronic disease and those with wheezing were excluded.
A chest X-ray ﬁlm (antero-posterior and lateral
views) was obtained in all children. White blood cell
(WBC) count, C-reactive protein (CRP) and blood cul-
tures were obtained in children with stage 2 and 3
pneumonia. Amoxyclavulanate was used for initial oral
therapy (stage 1) and follow-up oral therapy (stages 2
and 3), and ceftriaxone for initial parenteral therapy
(stages 2 and 3). Simple statistical analysis was done
using the chi-squared test (level of signiﬁcance deﬁned as
P<0.05).
Over the 6 months study period, 47 children fulﬁlling
the WHO criteria of pneumonia were enrolled. The
median age was 28 months (range, 4 to 59 months).
Seventeen children (36%) were classiﬁed as stage 1
pneumonia, 22 (47%) as stage 2, and 8 (17%) as stage 3
(Table 1). Clinical outcome was favourable in all chil-
dren.
The overall poor sensitivity of auscultation, which
proved normal in 70% of children is worth noting.
Auscultation was able to detect only 33% of consoli-
dations evidenced on chest ﬁlms. Chest X-ray ﬁlms
proved to have an excellent sensitivity with abnormal
ﬁndings in 98% of cases. A consolidation was evidenced
in 92% of children meeting the WHO clinical criteria of
pneumonia. In one child with stage 3 pneumonia and
abnormal auscultatory ﬁndings, the chest X-ray ﬁlm was
normal on initial work-up but showed a consolidation
24 h later. This delay in the anatomical consolidation
process has been well described in the literature [1]. We
did not study the speciﬁcity of the chest X-ray examin-
ation (proportion of ﬁlms showing a consolidation in
children without tachypnoea). To our knowledge, only
one investigation has speciﬁcally addressed the issue and
came up with a value of 67% [5]. Pleural eﬀusions were
found in all three clinical stages of pneumonia. Overall,
an eﬀusion was detected in 17 % of cases. It was more
frequent in stage 3 pneumonia with 50% of children
having some degree of pleural eﬀusion. There were no
statistically signiﬁcant diﬀerences between groups,
probably because numbers of subjects were insuﬃcient
to reach statistical signiﬁcance.
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Tachypnoea is as good a diagnostic criterion as the
combination of clinical and radiological signs of con-
solidation. This ﬁnding does strongly question the use of
routine chest X-ray examination in the initial evaluation
of children suspected to have a CAP. A WBC count
above the cut-oﬀ point of 15 g/l and CRP values greater
than 60 mg/l [3] were found in 53% and 67% of patients
with stage 2 or 3 pneumonia respectively. The propor-
tion of cases with WBC counts and CRP values above
the deﬁned cut-oﬀ points was 88% in children with stage
3 pneumonia. In our opinion, the ﬁnding of elevated
WBC counts and CRP levels does not provide much
additional information and we consider these investi-
gations to be of limited usefulness.
Investigating the microbial aetiology of RTIs was not
the aim of this study. We limited our investigations to
obtaining blood cultures in stage 2 and 3 pneumonia.
They were positive for Streptococcus pneumoniae in 5%
of patients with stage 2 pneumonia as opposed to 38%
of children with stage 3 disease. This suggests that the
probability is low for blood culture results to have
a practical impact on management. In our view
blood cultures should not be obtained in stage 1 or 2
pneumonia. Further work should aim at validating the
simple clinical approach of RTIs advocated by the
WHO in view of speciﬁc causative pathogens in order to
determine the proportion of viral infections being in-
appropriately treated with antibiotics, and at evaluating
the diagnostic usefulness in this ﬁeld of new biological
markers of infection such as procalcitonin [4].
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Table 1. Summary of results
WHO stage 1 2 3 Subtotal Total
17 (36) 22 (47) 8 (17) 47
Auscultation
Normal (n) (%) 13 (76) 16 (73) 4 (50) 33 (70) 47
Abnormal (n) (%) 4 (24) 6 (27) 4 (50) 14 (30)
Chest X-ray ﬁlm
Normal (n) 0 0 1 1 47
Consolidation (n) 16 20 7 43
Diﬀuse inﬁltrate (n) 1 2 0 3
Correlation between auscultation
and X-ray consolidation (%)
25 30 57 33
Pleural eﬀusion (n) (%) 2 (12) 2 (9) 4 (50) 8 (17)
WBC count >15 g/l (n) (%) NA 9 (41) 7 (88) 16 (53)
CRP level >60 mg/l (n) (%) NA 13 (59) 7 (88) 20 (67)
Blood culture positive for Streptococcus
pneumoniae (n) (%)
NA 1 (5) 3 (38) 2 (12)
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